Targeted next-generation sequencing identified a mutation in NPM1 and according to the WHO 5th edition criteria, the patient was diagnosed with acute myeloid leukemia (AML) with NPM1 mutation. This evidence concerns the gene NPM1 and acute myeloid leukemia.